Empagliflozin increases plasma levels of citrulline, histidine, and α-aminobutyric acid in patients with type 2 diabetes: effects of a sodium-glucose co-transporter 2 inhibitor on the plasma amino acid profile.

Expert opinion on pharmacotherapy2024Jojima T, Sakurai S, Kishi H, et al.

Study designRandomized controlled trial

SubjectHuman

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

AgedAmino AcidsBenzhydryl CompoundsCitrullineDiabetes Mellitus, Type 2FemaleGlucosidesHistidineHumansHypoglycemic AgentsMaleMiddle AgedSodium-Glucose Transporter 2 Inhibitors

DOI 10.1080/14656566.2024.2362265

PMID 38809611

View source →